αDC1 vaccine

BIOLOGICAL2 trials

Sponsors

Pawel Kalinski, Kalinski, Pawel, MD, PhD

Conditions

Metastatic Colorectal CancerOvarian Cancer

Phase 2

A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal Cancer

WithdrawnNCT02615574

Pawel KalinskiMetastatic Colorectal Cancer

Start: 2016-03-31End: 2018-12-31Updated: 2017-09-26

Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer

Not yet recruitingNCT07634094

Kalinski, Pawel, MD, PhDOvarian Cancer

Start: 2026-08-01End: 2029-08-01Target: 28Updated: 2026-06-08